NATALICCHIO, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 5.963
EU - Europa 2.222
AS - Asia 1.235
SA - Sud America 143
AF - Africa 12
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.584
Nazione #
US - Stati Uniti d'America 5.947
CN - Cina 650
SE - Svezia 525
IT - Italia 495
SG - Singapore 424
RU - Federazione Russa 399
DE - Germania 212
UA - Ucraina 199
FI - Finlandia 150
BR - Brasile 134
GB - Regno Unito 87
IN - India 41
BE - Belgio 38
ID - Indonesia 38
FR - Francia 31
AT - Austria 24
NL - Olanda 24
IE - Irlanda 17
CA - Canada 13
HK - Hong Kong 13
TR - Turchia 9
VN - Vietnam 8
IQ - Iraq 7
KR - Corea 7
BD - Bangladesh 5
JP - Giappone 5
PK - Pakistan 5
AU - Australia 4
EU - Europa 4
VE - Venezuela 4
AZ - Azerbaigian 3
CH - Svizzera 3
IR - Iran 3
KE - Kenya 3
MA - Marocco 3
NO - Norvegia 3
PH - Filippine 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
HU - Ungheria 2
LB - Libano 2
MX - Messico 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GA - Gabon 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.584
Città #
Chandler 696
Fairfield 577
Woodbridge 511
Jacksonville 496
Nyköping 436
Houston 346
Ashburn 345
Ann Arbor 280
Cambridge 259
Singapore 254
Dearborn 211
Seattle 203
Wilmington 180
Roxbury 149
Bari 148
Lawrence 140
Nanjing 134
Beijing 113
Boardman 105
New York 99
Des Moines 89
Inglewood 80
Princeton 61
San Diego 47
Helsinki 40
Los Angeles 39
Brooklyn 38
Brussels 38
Jakarta 36
Jiaxing 35
Moscow 34
Nanchang 33
Hebei 32
Shenyang 29
Hefei 27
London 25
Tianjin 23
Munich 22
Redwood City 22
Santa Clara 22
Falkenstein 20
Guangzhou 20
Pune 20
Rome 20
Jinan 18
Kunming 18
Dublin 15
Trinitapoli 13
Hong Kong 12
Paris 12
Wuhan 12
Zhengzhou 12
Changsha 11
Shanghai 11
Vienna 11
Frankfurt am Main 10
Nuremberg 10
São Paulo 10
Washington 9
Amsterdam 8
Dong Ket 8
Taizhou 8
Fuzhou 7
Altay 6
Hangzhou 6
Milan 6
Naples 6
Ottawa 6
Auburn Hills 5
Belo Horizonte 5
Chengdu 5
Falls Church 5
Hounslow 5
Norwalk 5
Bengaluru 4
Berlin 4
Columbus 4
Costa Mesa 4
Grafing 4
Hyderabad 4
Kolkata 4
Shenzhen 4
Toronto 4
Ahmedabad 3
Augusta 3
Baku 3
Baotou 3
Campo Grande 3
Chaoyang 3
Chongqing 3
Cutrofiano 3
Lahore 3
Lecce 3
Mottola 3
Nairobi 3
Nanning 3
Ningbo 3
North Bergen 3
Quzhou 3
San Francisco 3
Totale 6.896
Nome #
Long-term exposure of pancreatic β-cells to palmitate results in SREBP-1C-dependent decreases in GLP-1 receptor signaling via CREB and AKT and insulin secretory response 154
Reduced SIRT1 and SIRT2 expression promotes adipogenesis of human visceral adipose stem cells and associates with accumulation of visceral fat in human obesity 152
Correction of intermittent hypoxia reduces inflammation in obese subjects with obstructive sleep apnea 144
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 142
Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases 138
GLP-1: a new approach for type 2 diabetes therapy 134
Abnormalities of insulin-like growth factor-l Signaling and Impaired Cell Proliferation in Osteoblasts from Subjects with Osteoporosis 129
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 115
The p66Shc redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells 115
The p66Shc Protein Controls Redox Signaling and Oxidation-Dependent DNA Damage in Human Liver Cells 114
Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway. 112
GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells 111
Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain 110
Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane 109
Insulin and Insulin Receptors in Adipose Tissue Development 109
Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway 103
Differences in gene expression and cytokine release profiles highlight the heterogeneity of distinct subsets of adipose tissue-derived stem cells in the subcutaneous and visceral adipose tissue in humans. 101
The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis 100
Exploiting the pleiotropic actions of GLP-1 for the management of type 2 diabetes mellitus and its complications. 96
Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts 94
Effects of Extra Virgin Olive Oil Polyphenols on Pancreatic Beta-Cell Function and Survival 94
Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study 94
TNFα Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells 89
null 89
Decreased IRS phosphorylation and altered Erk activation in osteoblasts from osteoporotic subjects. 85
Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling 85
Insulin signaling in human visceral and subcutaneous adipose tissue in vivo 82
Abnormalities in IGF-I signalling and impaired cell proliferation in osteoblasts from patients with osteoporosis. 80
Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis 80
The myokine irisin is released in response to saturated fatty acids and promotes pancreatic β-cell survival and insulin secretion 78
Multifactorial intervention in type 2 diabetes: the promise of incretin-based therapies 74
Involvement of Actin Cytoskeleton in Free Fatty Acid-induced Beta-Cell Death. 73
Role of UBC9 in the regulation of the adipogenic program in 3T3-L1 adipocytes 73
Chronic palmitate excess results in reduced exendin-4 action and signalling via CREB and Akt in pancreatic beta cells 73
Dysmetabolic adipose tissue in obesity: morphological and functional characteristics of adipose stem cells and mature adipocytes in healthy and unhealthy obese subjects 73
Key role of the p66Shc protein in the regulation of the glucose transport system in skeletal muscle cells. 71
Associated hormonal declines in aging: DHEAS 71
Correction of Intermittent Hypoxia with CPAP Improves Cardiometabolic Abnormalities, and Systemic and Adipose Tissue Inflammation in Obese Subjects with Obstructive Sleep Apnea. 70
Cross-Talk between PPARgamma and Insulin Signaling and Modulation of Insulin Sensitivity 70
Comparison of Distinct GLP-1 Receptor Agonists in Palmitate-induced Incretin Resistance of Pancreatic Beta Cells 70
The SUMO-conjugating enzyme Ubc9 is essential for insulin-responsive glucose transport in adipocytes. 69
The p66Shc protein controls glucose transport responses in skeletal muscle cells through Erk-dependent regulation of the actin cytoskeleton. 69
null 68
Role of the p66Shc isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblasts 68
p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress 67
Irisin Enhances Pancreatic Beta-Cell Survival and Insulin Secretion and Can Mediate the Metabolic Cross Talk between the Skeletal Muscle and Endocrine Pancreas 67
The p66Shc isoform mediates FFA-induced apoptosis in pancreatic beta-cells. 65
Specific metabolic effects of insulin detemir in human visceral adipocytes differentiated in vitro from precursor stromal cells. 65
Role of p66Shc in cytokine-mediated leukocyte recruitment by endothelial cells. 65
The myokine irisin is released in response to saturated fatty acids and enhances pancreatic beta cell survival and insulin secretion 65
Functional loss of pancreatic islets in type 2 diabetes: How can we halt it? 65
Mitogenic and metabolic responses to IGF-I are dysregulated in osteoblasts from osteoporotic patients. 64
The p66Shc isoform is essential for induction and maintenance of a normal skeletal muscle cell phenotype in response to growth factors. 64
Association of Hashimoto’s thyroiditis and nodular pathology: is there an increased risk for thyroid papillary carcinoma? 64
Role of the p66Shc isoform in IGF-I receptor signaling through MEK/ERK and regulation of actin cytoskeleton in rat myoblasts 64
Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity. 63
Requirement of the SUMO-conjugating enzyme Ubc9 for insulin-responsive glucose transport in adipocytes. 62
Role of the SUMO-conjugating enzyme Ubc9 in adipocyte differentiation 62
Role of p66Shc in the modulation of oxidative stress in human liver cells. 61
TNF alpha impairs insulin signaling in pancreatic beta-cells through JNK-dependent serine phosphorylation of IRS-2. 61
Enhanced Adipo/Lipogenic Potential of Human Adipose Tissue Stem Cells in Obesity 61
Effects of irisin on leptin and ghrelin secretion and expression of the major appetite regulators in mouse brain 61
Enhanced adipo/lipogenic potential oh human adipose tissue stem cells in obesity. 60
Mechanisms of glucose transport stimulation by dehydroepiandrosterone (DHEA) in cultured adipocytes. 60
Role of p66Shc in the modulation of endothelial leukocyte recruitment 60
The p66Shc protein mediates saturated fatty acid-induced insulin resistance in pancreatic beta cells 59
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 59
Dehydroepiandrosterone exerts distinct regulatory effects on the glucose transport system in fat and muscle cells. 58
The p66Shc isoform modulates IGF-I stimulation of Akt phosphorylation in human thyroid carcinoma cells. 58
The p66Shc isoform controls the actin cytoskeleton and the glucose transport system in skeletal muscle cells. 58
Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis 58
The p66Shc isoform inhibits MAP kinase signaling and regulates IGF-mediated proliferation and differentiation in skeletal muscle cells. 57
The DPP-IV inhibitor saxagliptin inhibits palmitate-induced apoptosis of human umbilical vein endothelial cells and human cardiac progenitors 57
Role of p66Shc in Cytokine-Mediated Leukocyte Recruitment by Endothelial Cells 57
Depot-related differences in insulin action and signaling, gene expression, and adiponectin secretion in human adipocytes differentiated in vitro from precursor stromal cells. 56
Involvement of actin cytoskeleton in free fatty acid-induced beta cell death 56
Opposite effects of dehydroepiandrosterone (DHEA) on the glucose transport system in fat and skeletal muscle cells. 55
The Adipogenic Potential of Human Adipose Tissue Precursor Cells Is Regulated in a Fat Depot- and BMI-Dependent Manner 55
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 55
Predictive value for malignancy of ultrasound and color-doppler features of thyroid nodules. 54
Insulin Detemir Induced less Adipogenesis and less Lipid Droplets Accumulation than Human Insulin in Human Adipose Stem Cells 53
GLP-1 receptor agonists modulate TNFα signaling and TNFα-induced apoptosis in INS-1 beta-cells. 53
Role of Ubc9 in the development of insulin-responsive glucose transport during adipocyte differentiation. 53
Differences in insulin action and metabolic responses between human visceral and subcutaneous adipicytes differentiated in vitro from precursor stromal cells. 53
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial 52
Loss of p66Shc and impairment of Akt activation by IGF-I in human thyroid cancer cells. 52
The p66Shc isoform is essential for induction and maintenance of a normal skeletal muscle cell phenotype in response to insulin-like growth factors. 51
Genetic mutation of p66Shc protein at Ser36 prevents oxidative stress human liver cells. 51
Protective effects of GLP-1 receptor agonists on TNFα-induced apoptosis in INS-1 beta cells. 51
The SUMO-conjugating enzyme Ubc9 Is essential in adipocyte differentiation. 50
Exendin-4 inhibits palmitate-induced apoptosis of human cardiac progenitors cells. 50
Molecular mechanisms of glucose transport stimulation by dehydroepiandrosterone (DHEA) in cultured adipocytes and myocytes. 50
The adipogenic potential of human adipose tissue precursor cells is regulated in a fat depot- and BMI- dependent manner. 50
Distinct gene expression and cytokine release profiles identify three different adipose tissue progenitor cells in abdominal subcutaneous and visceral adipose tissue. 50
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes 50
Exendin-4 Inhibits Palmitate-Induced Apoptosis of Human Cardiac Progenitor Cells 49
Involvement of p66Shc in TNFα-induced endothelial dysfunction. 49
Strategie per la prevenzione della disfunzione beta-cellulare nel diabete mellito tipo 2. 48
Exendin-4 inhibits palmitate-induced apoptosis in pancreatic beta-cells. 48
Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells 48
Totale 7.419
Categoria #
all - tutte 48.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.221


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020396 0 0 0 0 0 0 0 0 0 179 178 39
2020/20211.111 106 43 118 28 222 41 89 80 126 142 63 53
2021/20221.084 44 132 9 82 34 53 31 68 62 63 211 295
2022/20231.951 227 226 112 156 255 318 24 211 346 18 39 19
2023/2024717 57 134 34 69 85 177 9 51 4 27 4 66
2024/20251.657 49 49 221 108 102 328 300 327 163 10 0 0
Totale 9.967